Cited by 820Nerve injury and regenerationAlzheimer's disease research and treatmentsParkinson's Disease Mechanisms and Treatments

The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.

GDNF, NGF and BDNF as therapeutic options for neurodegeneration

Allen, Shelley J., Watson, Judy J., Shoemark, Deborah K., Barua, Neil U., Patel, Nikunj K.·2013·Pharmacology & Therapeutics

DOI 10.1016/j.pharmthera.2013.01.004

Open this paper in CoChat — free account

Abstract

Glial cell-derived neurotrophic factor (GDNF), and the neurotrophin nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) are important for the survival, maintenance and regeneration of specific neuronal populations in the adult brain. Depletion of these neurotrophic factors has been linked with disease pathology and symptoms, and replacement strategies are considered as potential therapeutics for neurodegenerative diseases such as Parkinson's, Alzheimer's and Huntington's diseases. GDNF administration has recently been shown to be an effective treatment for Parkinson's disease, with clinical trials currently in progress. Trials with NGF for Alzheimer's disease are ongoing, with some degree of success. Preclinical results using BDNF also show much promise, although there are accompanying difficulties. Ultimately, the administration of a therapy involving proteins in the brain has inherent problems. Because of the blood-brain-barrier, the protein must be infused directly, produced by viral constructs, secreted from implanted protein-secreting cells or actively transported across the brain. An alternative to this is the use of a small molecule agonist, a modulator or enhancer targeting the associated receptors. We evaluate these neurotrophic factors as potential short or long-term treatments, weighing up preclinical and clinical results with the possible effects on the underlying neurodegenerative process.

Integrity signals

Registry

Crossref · 10.1016/j.pharmthera.2013.01.004

Cites

256 of 256 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons
Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S. L., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,206
Amyotrophic lateral sclerosis
Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61156-7 · Cited by 2,603
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
The GDNF family: Signalling, biological functions and therapeutic value
Airaksinen, M. S., & Saarma, M. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn812 · Cited by 1,862
Purification of a new neurotrophic factor from mammalian brain.
Barde, Y. A., Edgar, D., & Thoenen, H. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01207.x · Cited by 1,822
A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: Report of 35 cases
Hagberg, B. A., Aicardi, J. F., Dias, K., & Ramos, O. (1983) · Annals of Neurology · doi:10.1002/ana.410140412 · Cited by 1,515
BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
Hyman, C., Hofer, M., Barde, Y., Juhasz, M., Yancopoulos, G. D., Squinto, S. P., & Lindsay, R. M. (1991) · Nature · doi:10.1038/350230a0 · Cited by 1,503
Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Molecular cloning and expression of brain-derived neurotrophic factor
Leibrock, J., Lottspeich, F., Hohn, A., Hofer, M., Hengerer, B., Masiakowski, P., Thoenen, H., & Barde, Y. (1989) · Nature · doi:10.1038/341149a0 · Cited by 1,472
Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor.
Korte, M., Carroll, P., Wolf, E., Brem, G., Thoenen, H., & Bonhoeffer, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8856 · Cited by 1,426
Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders
Autry, A. E., & Monteggia, L. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005108 · Cited by 1,390
The yin and yang of neurotrophin action
Lu, B., Pang, P. T., & Woo, N. H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1726 · Cited by 1,356
Neurotrophin-3: a Neurotrophic Factor Related to NGF and BDNF
Maisonpierre, P. C., Belluscio, L., Squinto, S., Ip, N. Y., Furth, M. E., Lindsay, R. M., & Yancopoulos, G. D. (1990) · Science · doi:10.1126/science.2321006 · Cited by 1,322
NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIES
Bowen, D. M., Smith, C. B., White, P., & DAVISON, A. N. (1976) · Brain · doi:10.1093/brain/99.3.459 · Cited by 1,313
APRIORITY
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,293
Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease
Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Svendsen, C. N., & Heywood, P. (2003) · Nature Medicine · doi:10.1038/nm850 · Cited by 1,290
Self-citation
Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules
Gauthier, L. R., Charrin, B. C., Borrell-Pagès, M., Dompierre, J. P., Rangone, H., Cordelières, F. P., De Mey, J., MacDonald, M. E., Leßmann, V., Humbert, S., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.018 · Cited by 1,178
Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication
Chen, B., Dowlatshahi, D., MacQueen, G. M., Wang, J.-F., & Young, L. T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01083-6 · Cited by 1,164
Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer Type
Summers, W. K., Majovski, L. V., Marsh, G. M., Tachiki, K. H., & Kling, A. S. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611133152001 · Cited by 1,161
Cleavage of proBDNF by tPA/Plasmin Is Essential for Long-Term Hippocampal Plasticity
Pang, P. T., Teng, H. K., Zaitsev, E., Woo, N. T., Sakata, K., Zhen, S., Teng, K. K., Yung, W.-H., Hempstead, B. L., & Lu, B. (2004) · Science · doi:10.1126/science.1100135 · Cited by 1,136
Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease
Zuccato, C., Ciammola, A., Rigamonti, D., Leavitt, B. R., Goffredo, D., Conti, L., MacDonald, M. E., Friedlander, R. M., Silani, V., Hayden, M. R., et al. (2001) · Science · doi:10.1126/science.1059581 · Cited by 1,123
NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA
Perry, E., Perry, R., Blessed, G., & Tomlinson, B. E. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91780-9 · Cited by 1,070
Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons
Crowley, C. W., Spencer, S. D., Nishimura, M. C., Chen, K. S., Pitts-Meek, S., Armaninl, M. P., Ling, L. H., McMahon, S. B., Shelton, D. L., Levinson, A. D., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90378-6 · Cited by 1,068
Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection.
Williams, L. R., Varon, S. S., Peterson, G. M., Wictorin, K., Fischer, W., Björklund, A., & Gage, F. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.9231 · Cited by 1,055
ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Cramer, P. E., Cirrito, J. R., Wesson, D. W., Lee, C. Y. D., Karlo, J. C., Zinn, A. E., Casali, B. T., Restivo, J. L., Goebel, W. D., James, M. J., et al. (2012) · Science · doi:10.1126/science.1217697 · Cited by 1,050
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
Tuszynski, M. H., Thal, L., Pay, M., Salmon, D. P., U, H. S., Bakay, R., Patel, P., Blesch, A., Vahlsing, H. L., Ho, G., et al. (2005) · Nature Medicine · doi:10.1038/nm1239 · Cited by 1,050
Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease
Nagahara, A. H., Merrill, D. A., Coppola, G., Tsukada, S., Schroeder, B. E., Shaked, G. M., Wang, L., Blesch, A., Kim, A., Conner, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1912 · Cited by 1,034
Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor
Fischer, W., Wictorin, K., Björklund, A., Williams, L., Varon, S. S., & Gage, F. H. (1987) · Nature · doi:10.1038/329065a0 · Cited by 1,024
Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease
Lang, A. E., Gill, S., Patel, N., Lozano, A., Nutt, J. G., Penn, R., Brooks, D. J., Hotton, G. R., Moro, E., Heywood, P., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20737 · Cited by 987
Self-citation
Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene
Smeyne, R. J., Klein, R., Schnapp, A., Long, L. K., Bryant, S., Lewin, A. C., Lira, S. A., & Barbacid, M. (1994) · Nature · doi:10.1038/368246a0 · Cited by 980
Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes
Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., Cataudella, T., Leavitt, B. R., Hayden, M. R., Timmusk, T., et al. (2003) · Nature Genetics · doi:10.1038/ng1219 · Cited by 979
Sortilin is essential for proNGF-induced neuronal cell death
Nykjaer, A., Lee, R., Teng, K. K., Jansen, P., Madsen, P., Nielsen, M. S., Jacobsen, C., Kliemannel, M., Schwarz, E., Willnow, T. E., et al. (2004) · Nature · doi:10.1038/nature02319 · Cited by 962
Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo
Levi‐Montalcini, R., & Hamburger, V. (1951) · Journal of Experimental Zoology · doi:10.1002/jez.1401160206 · Cited by 958
Brain-derived neurotrophic factor in neurodegenerative diseases
Zuccato, C., & Cattaneo, E. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.54 · Cited by 947
Nerve Growth Factor Treatment After Brain Injury Prevents Neuronal Death
Kromer, L. F. (1987) · Science · doi:10.1126/science.3798108 · Cited by 932
BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease
Phillips, H. S., Hains, J. M., Armanini, M., Laramee, G. R., Johnson, S. A., & Winslow, J. W. (1991) · Neuron · doi:10.1016/0896-6273(91)90273-3 · Cited by 921
p75 and Trk: A two-receptor system
Chao, M. V., & Hempstead, B. L. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93922-k · Cited by 857
Neurotrophin-5: A novel neurotrophic factor that activates trk and trkB
Berkemeier, L. R., Winslow, J. W., Kaplan, D. R., Nikolics, K., Goeddel, D. V., & Rosenthal, A. (1991) · Neuron · doi:10.1016/0896-6273(91)90287-a · Cited by 836
Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in xenopus ovary
Hallböök, F., Ibáñez, C. F., & Persson, H. (1991) · Neuron · doi:10.1016/0896-6273(91)90180-8 · Cited by 834
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD
Nutt, J. G., Burchiel, K. J., Comella, C., Jankovic, J. J., Lang, A. E., Laws, E. R., Lozano, A. M., Penn, R. D., Simpson, R. K., Stacy, M. A., et al. (2003) · Neurology · doi:10.1212/wnl.60.1.69 · Cited by 816
Activation of p75NTR by proBDNF facilitates hippocampal long-term depression
Woo, N. H., Teng, H. K., Siao, C.-J., Chiaruttini, C., Pang, P. T., Milner, T. A., Hempstead, B. L., & Lu, B. (2005) · Nature Neuroscience · doi:10.1038/nn1510 · Cited by 815
A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences
Martı́n-Zanca, D., Hughes, S. H., & Barbacid, M. (1986) · Nature · doi:10.1038/319743a0 · Cited by 812
GDNF signalling through the Ret receptor tyrosine kinase
Durbec, P. L., Marcos-Gutierrez, C. V., Kilkenny, C., Grigoriou, M. E., Wartiovaara, K., Suvanto, P., Smith, D. P., Ponder, B. A. J., Costantini, F. D., Saarma, M., et al. (1996) · Nature · doi:10.1038/381789a0 · Cited by 811
Functional receptor for GDNF encoded by the c-ret proto-oncogene
Trupp, M., Arenas, E., Fainzilber, M., Nilsson, A.-S., Sieber, B.-A., Grigoriou, M. E., Kilkenny, C., Salazar‐Grueso, E. F., Pachnis, V., Arumäe, U., et al. (1996) · Nature · doi:10.1038/381785a0 · Cited by 795
Untitled work
(1966) · PubMed · Cited by 708
Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section
Sendtner, M., Holtmann, B., Kolbeck, R., Thoenen, H., & Barde, Y. (1992) · Nature · doi:10.1038/360757a0 · Cited by 706
Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promoters
Pruunsild, P., Kazantseva, A., Aid, T., Palm, K., & Timmusk, T. (2007) · Genomics · doi:10.1016/j.ygeno.2007.05.004 · Cited by 699
A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer disease
Appel, S. H. (1981) · Annals of Neurology · doi:10.1002/ana.410100602 · Cited by 698
Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer’s disease
Peng, S., Wuu, J., Mufson, E. J., & Fahnestock, M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03135.x · Cited by 691
A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
Jang, S., Liu, X., Yepes, M., Shepherd, K. R., Miller, G. W., Liu, Y., Wilson, W. D., Xiao, G., Blanchi, B., Sun, Y. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913572107 · Cited by 689
Role of neurotrophic factors in depression
CASTREN, E., VOIKAR, V, & RANTAMAKI, T. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.009 · Cited by 667
Neurotrophin signalling in health and disease
Chao, M. V., Rajagopal, R., & Lee, F. S. (2006) · Clinical Science · doi:10.1042/cs20050163 · Cited by 628
The Neural Cell Adhesion Molecule NCAM Is an Alternative Signaling Receptor for GDNF Family Ligands
Paratcha, G., Ledda, F., & Ibáñez, C. F. (2003) · Cell · doi:10.1016/s0092-8674(03)00435-5 · Cited by 627
Evidence for Degenerative and Regenerative Changes in Neostriatal Spiny Neurons in Huntington's Disease
Graveland, G. A., Williams, R. S., & DiFiglia, M. (1985) · Science · doi:10.1126/science.3155875 · Cited by 612
Brain-derived neurotrophic factor is reduced in Alzheimer's disease
Connor, B., Young, D., Yan, Q., Faull, R. L. M., Synek, B., & Dragunow, M. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00125-3 · Cited by 581
Nanomaterial Toxicity Testing in the 21st Century: Use of a Predictive Toxicological Approach and High-Throughput Screening
Nel, A. E., Xia, T., Meng, H., Wang, X., Lin, S., Ji, Z., & Zhang, H. (2012) · Accounts of Chemical Research · doi:10.1021/ar300022h · Cited by 581
The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression
Chang, Q., Khare, G., Dani, V., Nelson, S., & Jaenisch, R. (2006) · Neuron · doi:10.1016/j.neuron.2005.12.027 · Cited by 578
Postural deformities in Parkinson's disease
Doherty, K. M., van de Warrenburg, B. P., Peralta, M. C., Silveira-Moriyama, L., Azulay, J.-P., Gershanik, O. S., & Bloem, B. R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70067-9 · Cited by 537
A NERVE GROWTH-STIMULATING FACTOR ISOLATED FROM SARCOM AS 37 AND 180
Cohen, S., Levi‐Montalcini, R., & Hamburger, V. (1954) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.40.10.1014 · Cited by 530
Region-Specific Neurotrophin Imbalances in Alzheimer Disease: Decreased Levels of Brain-Derived Neurotrophic Factor and Increased Levels of Nerve Growth Factor in Hippocampus and Cortical Areas
Hock, C., Heese, K., Hulette, C., Rosenberg, C., & Otten, U. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.846 · Cited by 523
Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra
Howells, D. W., Porritt, M. J., Wong, J. Y. F., Batchelor, P. E., Kalnins, R., Hughes, A. J., & Donnan, G. A. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7483 · Cited by 513
Complementary and Overlapping Expression of Glial Cell Line-Derived Neurotrophic Factor (GDNF), c-ret Proto-Oncogene, and GDNF Receptor-α Indicates Multiple Mechanisms of Trophic Actions in the Adult Rat CNS
Trupp, M., Belluardo, N., Funakoshi, H., & Ibáñez, C. F. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-10-03554.1997 · Cited by 504
The Precursor Pro-Nerve Growth Factor Is the Predominant Form of Nerve Growth Factor in Brain and Is Increased in Alzheimer's Disease
Fahnestock, M. L., Michalski, B., Xu, B., & Coughlin, M. D. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1016 · Cited by 501
Delivery of Neurotrophic Factors to the Central Nervous System: Pharmacokinetic Considerations
Thorne, R. G., & Frey, W. H. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140120-00003 · Cited by 487
The p75 neurotrophin receptor
Chao, M. V. (1994) · Journal of Neurobiology · doi:10.1002/neu.480251106 · Cited by 478
Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain
Mamounas, L., Blue, M., Siuciak, J. A., & Altar, C. A. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-12-07929.1995 · Cited by 474
Intracerebroventricular Infusion of Nerve Growth Factor in Three Patients with Alzheimer’s Disease
Jönhagen, M. E., Nordberg, A. K., Amberla, K., Bäckman, L., Ebendal, T., Meyerson, B. A., Olson, L., Seiger, Å., Shigeta, M., Theodorsson, E., et al. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017069 · Cited by 472
A Hundred Years of Alzheimer's Disease Research
Hardy, J. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.016 · Cited by 467
Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor
Scott, J., Selby, M., Urdea, M. S., Quiroga, M., Bell, G. I., & Rutter, W. J. (1983) · Nature · doi:10.1038/302538a0 · Cited by 466
Brain‐Derived Neurotrophic Factor Protects Dopamine Neurons Against 6‐Hydroxydopamine and N‐Methyl‐4‐Phenylpyridinium Ion Toxicity: Involvement of the Glutathione System
Spina, M. B., Squinto, S. P., Miller, J. M., Lindsay, R. M., & Hyman, C. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08880.x · Cited by 460
A controlled trial of recombinant methionyl human BDNF in ALS
The BDNF Study Group (Phase III) (1999) · Neurology · doi:10.1212/wnl.52.7.1427 · Cited by 453
Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor
Wiesmann, C., Ultsch, M. H., Bass, S., & de Vos, A. M. (1999) · Nature · doi:10.1038/43705 · Cited by 427
Presynaptic Cholinergic Dysfunction in Patients with Dementia
Sims, N. R., Bowen, D. M., Allen, S. J., Smith, C., Neary, D., Thomas, D. J., & DAVISON, A. N. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb11311.x · Cited by 421
Self-citation
GDNF is an age-specific survival factor for sensory and autonomic neurons
Buj‐Bello, A., Buchman, V. L., Horton, A. R., Rosenthal, A., & Davies, A. M. (1995) · Neuron · doi:10.1016/0896-6273(95)90173-6 · Cited by 410
BDNF and Full-length and Truncated TrkB Expression in Alzheimer Disease. Implications in Therapeutic Strategies
Ferrer, I., Marı́n, C., Rey, M. J., Ribalta, T., Goutan, E., Blanco, R., Tolosa, E. S., & Martı́, E. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199907000-00007 · Cited by 407
Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents
Massa, S. M., Yang, T., Xie, Y., Shi, J., Bilgen, M., Joyce, J. N., Nehama, D., Rajadas, J., & Longo, F. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41356 · Cited by 406
Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease
Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., Ichinose, H., & Nagatsu, T. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00463-2 · Cited by 404
Intraputamenal infusion of glial cell line–derived neurotrophic factor in PD: A two‐year outcome study
Patel, N. K., Bunnage, M., Plaha, P., Svendsen, C. N., Heywood, P. G., & Gill, S. S. (2005) · Annals of Neurology · doi:10.1002/ana.20374 · Cited by 384
Self-citation
Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion.
Sauer, H., Rosenblad, C., & Björklund, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8935 · Cited by 375
GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo
Arenas, E., Trupp, M., Åkerud, P., & Ibáñez, C. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90024-1 · Cited by 363
Virus-mediated gene transfer into hippocampal CA1 region restores long-term potentiation in brain-derived neurotrophic factor mutant mice.
Korte, M., Griesbeck, O., Gravel, C., Carroll, P., Staiger, V, Thoenen, H., & Bonhoeffer, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12547 · Cited by 351 · cited 2×
“, 1995) but can be rescued by, for instance, viral transfer of BDNF (Korte et al., 1996).”
Background
Brain-Derived Neurotrophic Factor Regulates the Onset and Severity of Motor Dysfunction Associated with Enkephalinergic Neuronal Degeneration in Huntington's Disease
Canals, J. M., Pineda, J. R., Torres-Peraza, J. F., Bosch, M., Martín‐Ibáñez, R., Muñoz, M. T., Mengod, G., Ernfors, P., & Alberch, J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1197-04.2004 · Cited by 345
Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion
Cooper, J. D., Salehi, A., Delcroix, J.-D., Howe, C. L., Belichenko, P. V., Chua-Couzens, J., Kilbridge, J. F., Carlson, E. J., Epstein, C. J., & Mobley, W. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181219298 · Cited by 336
Brain-derived neurotrophic factor in Huntington disease
Ferrer, I., Goutan, E., Marı́n, C., Rey, M. J., & Ribalta, T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02237-x · Cited by 333
Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease
Holsinger, R. M. D., Schnarr, J., Henry, P., Castelo, V. T., & Fahnestock, M. L. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00023-1 · Cited by 328
TrkA‐immunoreactive profiles in the central nervous system: Colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin
Sobreviela, T., Clary, D. O., Reichardt, L. F., Brandabur, M. M., Kordower, J. H., & Mufson, E. J. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903500407 · Cited by 324
Nerve growth factor affects11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (Case Report)
Olson, L., Nordberg, A. K., von Holst, H., Bäckman, L., Ebendal, T., Alafuzoff, I. I., Amberla, K., Hartvig, P., Herlitz, A., Lilja, A., et al. (1992) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02257624 · Cited by 323
Neurotrophin trafficking by anterograde transport
Altar, C. A., & DiStefano, P. S. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01273-9 · Cited by 319
Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats
Arancibia, S., Silhol, M., Mouliere, F. C., Meffre, J., Höllinger, I., Maurice, T., & Tapia‐Arancibia, L. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.05.012 · Cited by 319
Alzheimer's disease: synapses gone cold
Koffie, R. M., Hyman, B. T., & Spires‐Jones, T. L. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-63 · Cited by 316
GDNF Secreting Human Neural Progenitor Cells Protect Dying Motor Neurons, but Not Their Projection to Muscle, in a Rat Model of Familial ALS
Suzuki, M., McHugh, J., Tork, C. A., Shelley, B., Klein, S. M., Aebischer, P., & Svendsen, C. N. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000689 · Cited by 311
Reduced expression of brain-derived neurotrophic factor protein in Parkinsonʼs disease substantia nigra
Parain, K., Murer, M. G., Yan, Q., Faucheux, B. A., Agid, Y., Hirsch, É. C., & Raisman‐Vozari, R. (1999) · Neuroreport · doi:10.1097/00001756-199902250-00021 · Cited by 303
A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis
Ochs, G., Penn, R. D., York, M., Giess, R., Beck, M., Tonn, J., Haigh, J., Malta, E., Traub, M., Sendtner, M., et al. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515197 · Cited by 302
Dopaminergic neurons in rat ventral midbrain express brain‐derived neurotrophic factor and neurotrophin‐3 mRNAs
Seroogy, K. B., Lundgren, K. H., Tran, T. M., Guthrie, K. M., Isackson, P. J., & Gall, C. M. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903420302 · Cited by 299
Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases
Mufson, E. J., Kroin, J. S., Sendera, T. J., & Sobreviela, T. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00059-8 · Cited by 296
Glial cell line–derived neurotrophic factor induces neuronal sprouting in human brain
Love, S., Plaha, P., Patel, N. K., Hotton, G. R., Brooks, D. J., & Gill, S. S. (2005) · Nature Medicine · doi:10.1038/nm0705-703 · Cited by 285
Self-citation
Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75 ngfr , TrkA, TrkB, and TrkC) in the adult human peripheral nervous system and nonneural tissues
Yamamoto, M., Sobue, G., Yamamoto, K., & Mitsuma, T. (1996) · Neurochemical Research · doi:10.1007/bf02532343 · Cited by 283
7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, Reverses Memory Deficits and BACE1 Elevation in a Mouse Model of Alzheimer's Disease
Devi, L., & Ohno, M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.191 · Cited by 282
Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys
Grondin, R., Zhang, Z., Ai, Y., Cass, W. A., Maswood, N., Andersen, A. H., Elsberry, D. D., Klein, M. C., Gerhardt, G. A., & Gash, D. M. (2002) · Brain · doi:10.1093/brain/awf234 · Cited by 280
Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: A quantitative analysis across subregions of the basal forebrain
Mufson, E. J., Bothwell, M. A., & Kordower, J. H. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90124-6 · Cited by 279
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N., & Cattaneo, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6826 · Cited by 279
EFFECTS OF THE EXTRACT OF THE MOUSE SUBMAXILLARY SALIVARY GLANDS ON THE SYMPATHETIC SYSTEM OF MAMMALS*
Levi‐Montalcini, R., & Cohen, S. (1960) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1960.tb49963.x · Cited by 272
Suppressed Epileptogenesis in BDNF Mutant Mice
Kokaia, M., Ernfors, P., Kokaia, Z., Elmér, E., Jaenisch, R., & Lindvall, O. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1024 · Cited by 271
Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice
Simmons, D. A., Rex, C. S., Palmer, L. C., Pandyarajan, V., Fedulov, V., Gall, C. M., & LYNCH, G. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811228106 · Cited by 261
Point source concentration of GDNF may explain failure of phase II clinical trial
Salvatore, M. F., Ai, Y., FISCHER, B., ZHANG, A., Grondin, R., Zhang, Z., Gerhardt, G. A., & Gash, D. M. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.07.015 · Cited by 261
Short-Term GDNF Treatment Provides Long-Term Rescue of Lesioned Nigral Dopaminergic Neurons in a Rat Model of Parkinson’s Disease
Winkler, C., Sauer, H., Lee, C. S., & Björklund, A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-22-07206.1996 · Cited by 258
Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy
Smith, D. E., Roberts, J. A., Gage, F. H., & Tuszynski, M. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10893 · Cited by 244
Sortilin: a receptor to regulate neuronal viability and function
Nykjær, A., & Willnow, T. E. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.01.003 · Cited by 241
Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease
Crutcher, K. A., Scott, S. A., Liang, S., Everson, W. V., & Weingartner, J. A. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-06-02540.1993 · Cited by 233
RESEARCH ARTICLE: Systematic Assessment of BDNF and Its Receptor Levels in Human Cortices Affected by Huntington's Disease
Zuccato, C., Marullo, M., Conforti, P., MacDonald, M. E., Tartari, M., & Cattaneo, E. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00111.x · Cited by 231
Disruption of a Single Allele of the Nerve Growth Factor Gene Results in Atrophy of Basal Forebrain Cholinergic Neurons and Memory Deficits
Chen, K. S., Nishimura, M. C., Armanini, M. P., Crowley, C. W., Spencer, S. D., & PHILLIPS, H. S. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-19-07288.1997 · Cited by 227
Effect of 7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, on Emotional Learning
Andero, R., Heldt, S. A., Ye, K., Liu, X., Armario, A., & Ressler, K. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10030326 · Cited by 224
Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice
Capsoni, S., Giannotta, S., & Cattaneo, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192442999 · Cited by 215
The role of BDNF in the pathophysiology and treatment of schizophrenia
Favalli, G. P. D. S., Li, J., Belmonte-de-Abreu, P. S., Wong, A. H. C., & Daskalakis, Z. J. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.09.022 · Cited by 207
Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6‐OHDA lesion model depends on the site of administration of the trophic factor
Kirik, D., Rosenblad, C., & Björklund, A. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00274.x · Cited by 206
Food for thought: the role of dietary flavonoids in enhancing human memory, learning and neuro-cognitive performance
Spencer, J. P. E. (2008) · Proceedings of The Nutrition Society · doi:10.1017/s0029665108007088 · Cited by 195
Lessons from models of SOD1-linked familial ALS
Bendotti, C., & Carrı̀, M. T. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.06.009 · Cited by 194
In Situ Hybridization of trkB and trkC Receptor mRNA in Rat Forebrain and Association with High‐affinity Binding of [125I]BDNF, [125I]NT‐4/5 and [125I]NT‐3
Altar, C. A., Siuciak, J. A., Wright, P., Ip, N. Y., Lindsay, R. M., & Wiegand, S. J. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb01001.x · Cited by 190
Critical Role of Astroglial Apolipoprotein E and Liver X Receptor-α Expression for Microglial Aβ Phagocytosis
Terwel, D., Steffensen, K. R., Verghese, P. B., Kummer, M. P., Gustafsson, J.-Å., Holtzman, D. M., & Heneka, M. T. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6546-10.2011 · Cited by 190
Brain‐Derived Neurotrophic Factor, Neurotrophin‐3, and Neurotrophin‐4/5 Prevent the Death of Striatal Projection Neurons in a Rodent Model of Huntington's Disease
Pérez‐Navarro, E., Canudas, A. M., Åkerud, P., Alberch, J., & Arenas, E. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752190.x · Cited by 190
Brain‐derived neurotrophic factor over‐expression in the forebrain ameliorates Huntington’s disease phenotypes in mice
Gharami, K., Xie, Y., An, J. J., Tonegawa, S., & Xu, B. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05137.x · Cited by 184
GDNF fails to exert neuroprotection in a rat -synuclein model of Parkinson's disease
Decressac, M., Ulusoy, A., Mattsson, B., Georgievska, B., Romero‐Ramos, M., Kirik, D., & Björklund, A. (2011) · Brain · doi:10.1093/brain/awr149 · Cited by 184
Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease
Lynch, G., Kramar, E. A., Rex, C. S., Jia, Y., Chappas, D., Gall, C. M., & Simmons, D. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5113-06.2007 · Cited by 181
Small, Nonpeptide p75NTRLigands Induce Survival Signaling and Inhibit proNGF-Induced Death
Massa, S. M., Xie, Y., Yang, T., Harrington, A., Kim, M. L., Yoon, S. O., Kraemer, R. T., Moore, L. A., Hempstead, B. L., & Longo, F. M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3547-05.2006 · Cited by 180
Unilateral intraputamenal glial cell line–derived neurotrophic factor in patients with Parkinson disease: Response to 1 year of treatment and 1 year of withdrawal
Slevin, J. T., Gash, D. M., Smith, C. D., Gerhardt, G. A., Kryscio, R., Chebrolu, H., Walton, A., Wagner, R., & Young, A. B. (2007) · Journal of neurosurgery · doi:10.3171/jns.2007.106.4.614 · Cited by 173
Behavioural and neurochemical effects of chronic intraventricular injections of nerve growth factor in adult rats with fimbria lesions
Will, B. E., & Hefti, F. F. (1985) · Behavioural Brain Research · doi:10.1016/0166-4328(85)90004-x · Cited by 171
c-Src Is Required for Glial Cell Line-Derived Neurotrophic Factor (GDNF) Family Ligand-Mediated Neuronal Survival via a Phosphatidylinositol-3 Kinase (PI-3K)-Dependent Pathway
Encinas, M., Tansey, M. G., Pierchala, B. A., Comella, J. X., Milbrandt, J., & Johnson, E. M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01464.2001 · Cited by 169
Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurones
Zurn, A. D., Baetge, E. E., Hammang, J. P., et al. (1994) · Neuroreport · doi:10.1097/00001756-199412300-00030 · Cited by 168
Gambogic amide, a selective agonist for TrkA receptor that possesses robust neurotrophic activity, prevents neuronal cell death
Jang, S., Okada, M., Sayeed, I., Xiao, G., Stein, D. G., Jin, P., & Ye, K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706662104 · Cited by 158
Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson’s disease
Sun, M., Kong, L., Wang, X., Lu, X.-G., Gao, Q., & Geller, A. I. (2005) · Brain Research · doi:10.1016/j.brainres.2005.05.072 · Cited by 154
Expression and regulation of GFRα3, a glial cell line-derived neurotrophic factor family receptor
Naveilhan, P., Baudet, C., Mikaels, Å., Shen, L., Westphal, H., & Ernfors, P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1295 · Cited by 151
The Neuroprotective Agent Memantine Induces Brain-Derived Neurotrophic Factor and trkB Receptor Expression in Rat Brain
Marvanová, M., Lakso, M., Pirhonen, J., Nawa, H., Wong, G., & Ċastrén, E. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1027 · Cited by 150
Effective GDNF brain delivery using microspheres—A promising strategy for Parkinson's disease
Garbayo, E., Montero-Menei, C. N., Ansorena, E., Lanciego, J. L., Aymerich, M. S., & Blanco-Prieto, M. J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.12.010 · Cited by 150
Intraputamenal infusion of GDNF in aged rhesus monkeys: Distribution and dopaminergic effects
Ai, Y., Markesbery, W. R., Zhang, Z., Grondin, R., Elseberry, D., Gerhardt, G. A., & Gash, D. M. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10689 · Cited by 149
Intramuscular Grafts of Myoblasts Genetically Modified to Secrete Glial Cell Line-Derived Neurotrophic Factor Prevent Motoneuron Loss and Disease Progression in a Mouse Model of Familial Amyotrophic Lateral Sclerosis
Mohajeri, M. H., Figlewicz, D. A., & Bohn, M. C. (1999) · Human Gene Therapy · doi:10.1089/10430349950017536 · Cited by 148
Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease
Duan, W., Peng, Q., Masuda, N., Ford, E., Tryggestad, E. J., Ladenheim, B., Zhao, M., Cadet, J. L., Wong, J., & Ross, C. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.01.015 · Cited by 143
Twenty years of Alzheimer’s disease‐causing mutations
Goate, A., & Hardy, J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07575.x · Cited by 141
High-affinity nerve growth factor receptor (Trk) immunoreactivity is localized in cholinergic neurons of the basal forebrain and striatum in the adult rat brain
Steininger, T. L., Wainer, B. H., Klein, R., Barbacid, M., & Palfrey, H. C. (1993) · Brain Research · doi:10.1016/0006-8993(93)91681-h · Cited by 140
Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer’s disease
Leyhe, T., Stransky, E., Eschweiler, G. W., Buchkremer, G., & Laske, C. (2007) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0764-9 · Cited by 140
Reversible schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor
Winkler, J., Ramirez, G. A., Kuhn, H. G., Peterson, D. A., Day-Lollini, P. A., Stewart, G. R., Tuszynski, M. H., Gage, F. H., & Thal, L. J. (1997) · Annals of Neurology · doi:10.1002/ana.410410114 · Cited by 138
A Role for TrkA during Maturation of Striatal and Basal Forebrain Cholinergic NeuronsIn Vivo
Fagan, A. M., Garber, M., Barbacid, M., Silos‐Santiago, I., & Holtzman, D. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-20-07644.1997 · Cited by 138
Dose Response to Intraventricular Glial Cell Line-Derived Neurotrophic Factor Administration in Parkinsonian Monkeys
Zhang, Z., Miyoshi, Y., Lapchak, P. A., Collins, F., Hilt, D. C., LeBel, C. P., Kryscio, R. J., & Gash, D. M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36963-0 · Cited by 138
An Overview of Brain-Derived Neurotrophic Factor and Implications for Excitotoxic Vulnerability in the Hippocampus
Murray, P. S., & Holmes, P. V. (2011) · International Journal of Peptides · doi:10.1155/2011/654085 · Cited by 137
Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease
Fumagalli, F., Racagni, G., & Riva, M. A. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500360 · Cited by 135
Regeneration of the MPTP-Lesioned Dopaminergic System after Convection-Enhanced Delivery of AAV2-GDNF
Kells, A. P., Eberling, J. L., Su, X., Pivirotto, P., Bringas, J., Hadaczek, P., Narrow, W. C., Bowers, W. J., Federoff, H. J., Forsayeth, J., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0942-10.2010 · Cited by 135
Small Molecule, Non-Peptide p75NTR Ligands Inhibit Aβ-Induced Neurodegeneration and Synaptic Impairment
Yang, T., Knowles, J. K., Lu, Q., Zhang, H., Arancio, O., Moore, L. A., Chang, T., Wang, Q., Andreasson, K. I., Rajadas, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003604 · Cited by 134
Glial Cell Line-Derived Neurotrophic Factor Increases Stimulus-Evoked Dopamine Release and Motor Speed in Aged Rhesus Monkeys
Grondin, R., Cass, W. A., Zhang, Z., Stanford, J. A., Gash, D. M., & Gerhardt, G. A. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01974.2003 · Cited by 134
Brain Derived Neurotrophic Factor: A novel neurotrophin involved in psychiatric and neurological disorders
Balaratnasingam, S., & Janča, A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.01.006 · Cited by 133
Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease
Kirik, D., Georgievska, B., Rosenblad, C., & Björklund, A. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01534.x · Cited by 133
Genetics of Parkinson's disease
Gasser, T. (2004) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2004.6.3/tgasser · Cited by 133
GDNF Protection against 6-OHDA: Time Dependence and Requirement for Protein Synthesis
Kearns, C. M., Cass, W. A., Smoot, M. K., Kryscio, R. J., & Gash, D. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-18-07111.1997 · Cited by 131
Prevention of 6-hydroxydopamine-induced rotational behavior by BDNF somatic gene transfer
Klein, R. L., Lewis, M. H., Muzyczka, N., & Meyer, E. M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02116-2 · Cited by 128
Effects of brain‐derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease
Ikeda, K., Klinkosz, B., Greene, T., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410370413 · Cited by 126
Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons
Gall, C. M., Gold, S. J., Isackson, P. J., & Seroogy, K. B. (1992) · Molecular and Cellular Neuroscience · doi:10.1016/1044-7431(92)90009-q · Cited by 121
Signalling by glial cell line-derived neurotrophic factor (GDNF) requires heparan sulphate glycosaminoglycan
Barnett, M. W., Fisher, C. E., Perona‐Wright, G., & Davies, J. A. (2002) · Journal of Cell Science · doi:10.1242/jcs.00114 · Cited by 119
Safety Evaluation of AAV2-GDNF Gene Transfer into the Dopaminergic Nigrostriatal Pathway in Aged and Parkinsonian Rhesus Monkeys
Su, X., Kells, A. P., Huang, E. J., Lee, H. S., Hadaczek, P., Beyer, J., Bringas, J., Pivirotto, P., Penticuff, J., Eberling, J. L., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.103 · Cited by 118
Autonomic dysfunction in ALS: A preliminary study on the effects of intrathecal BDNF
Beck, M., Flachenecker, P., Magnus, T., Giess, R., Reiners, K., Toyka, K. V., & Naumann, M. K. (2005) · Amyotrophic Lateral Sclerosis · doi:10.1080/14660820510028412 · Cited by 117
Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS
Li, W., Brakefield, D., Pan, Y., Hunter, D., Myckatyn, T. M., & Parsadanian, A. S. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.028 · Cited by 117
Reduced transport of [125I]nerve growth factor by cholinergic neurons and down-regulated trka expression in the medial septum of aged rats
Cooper, J. D., Lindholm, D., & Sofroniew, M. V. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90462-6 · Cited by 116
Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease
Hall, A. M., Moore, R. Y., López, O. L., Kuller, L. H., & Becker, J. T. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.04.005 · Cited by 114
Nerve growth factor and the neurotrophic factor hypothesis
Yuen, E., Howe, C. L., Li, Y., Holtzman, D. M., & Mobley, W. C. (1996) · Brain and Development · doi:10.1016/0387-7604(96)00051-4 · Cited by 114
Specificity in Trk Receptor:Neurotrophin Interactions
Banfield, M. J., Naylor, R. L., Robertson, A., Allen, S. J., Dawbarn, D., & Brady, R. L. (2001) · Structure · doi:10.1016/s0969-2126(01)00681-5 · Cited by 113
Self-citation
A cell‐biological model of p75 NTR signaling
Blöchl, A., & Blöchl, R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04496.x · Cited by 112
Profound and Selective Loss of Catalytic TrkB Immunoreactivity in Alzheimer's Disease
Allen, S. J., Wilcock, G. K., & Dawbarn, D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1561 · Cited by 111
Self-citation
Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine
Ando, S., Kobayashi, S., Waki, H., Kon, K., Fukui, F., Tadenuma, T., Iwamoto, M., Takeda, Y., Izumiyama, N., Watanabe, K., et al. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10443 · Cited by 110
7,8-dihydroxyflavone exhibits therapeutic efficacy in a mouse model of Rett syndrome
Johnson, R. A., Lam, M. S. Y., Punzo, A. M., Li, H., Lin, B. R., Ye, K., Mitchell, G. S., & Chang, Q. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01361.2011 · Cited by 110
Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: Involvement of phospholipaseCγ activity and glutamate receptor expression
Giralt, A., Rodrigo, T., Martín, E. D., González, J. R., Milà, M., Ceña, V., Dierssen, M., Canals, J. M., & Alberch, J. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.024 · Cited by 109
Reprint: Six-Month Continuous Intraputamenal Infusion Toxicity Study of Recombinant Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) in Rhesus Monkeys
Hovland, D. N., Boyd, R. B., Butt, M. T., Engelhardt, J. A., Moxness, M. S., Ma, M. H., Emery, M. G., Ernst, N. B., Reed, R. P., Zeller, J. R., et al. (2007) · Toxicologic Pathology · doi:10.1177/01926230701481899 · Cited by 108
BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease
Giralt, A., Friedman, H. C., Caneda-Ferrón, B., Urbán, N., Moreno, E., Rubio, N., Blanco, J., Peterson, A. C., Canals, J. M., & Alberch, J. (2010) · Gene Therapy · doi:10.1038/gt.2010.71 · Cited by 106
Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction
Giralt, A., Carretón, O., Lao‐Peregrín, C., Martín, E. D., & Alberch, J. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-71 · Cited by 104
7,8‐dihydroxyflavone, a TrkB receptor agonist, blocks long‐term spatial memory impairment caused by immobilization stress in rats
Andero, R., Daviu, N., Escorihuela, R. M., Nadal, R. A., & Armario, A. (2010) · Hippocampus · doi:10.1002/hipo.20906 · Cited by 104
Coexistence of choline acetyltransferase and nerve growth factor receptors in the rat basal forebrain
Dawbarn, D., Allen, S. J., & Semenenko, F. M. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90284-4 · Cited by 102
Self-citation
Increased expression of brain-derived neurotrophic factor but not neurotrophin-3 mRNA in rat brain after cortical impact injury
Yang, K., Perez-Polo, J. R., Mu, X. S., Yan, H. Q., Xue, J. J., Iwamoto, Y., Liu, S. J., Dixon, C. E., & Hayes, R. L. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960415)44:2 · Cited by 102
GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys
Gerhardt, G. A., Cass, W. A., Huettl, P. F., Brock, S., Zhang, Z., & Gash, D. M. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01244-x · Cited by 98
A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results
Kalra, S., Genge, A. L., & Arnold, D. L. (2003) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820310006689 · Cited by 93
Clinically Relevant Effects of Convection-Enhanced Delivery of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Aged Rhesus Monkeys
Johnston, L. C., Eberling, J. L., Pivirotto, P., Hadaczek, P., Federoff, H. J., Forsayeth, J., & Bankiewicz, K. S. (2009) · Human Gene Therapy · doi:10.1089/hum.2008.137 · Cited by 92
Long‐term protection of the rat nigrostriatal dopaminergic system by glial cell line‐derived neurotrophic factor against 6‐hydroxydopamine in vivo
Sullivan, A. M., Opacka‐Juffry, & Blunt (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00016.x · Cited by 92
Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery
Lapchak, P. A., Miller, P. J., Collins, F., & Jiao, S. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)83045-x · Cited by 92
TGFβ induces GDNF responsiveness in neurons by recruitment of GFRα1 to the plasma membrane
Peterziel, H., Unsicker, K., & KRIEGLSTEIN, K. G. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200203115 · Cited by 91
Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis
Corona, J. C., Tovar‐y‐Romo, L. B., & Tapia, R. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.11.1415 · Cited by 91
Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice
Park, S., Kim, H.-T., Yun, S., Kim, I., Lee, J., Lee, I.-S., & Park, K. I. (2009) · Experimental & Molecular Medicine · doi:10.3858/emm.2009.41.7.054 · Cited by 90
Therapeutic potential of CERE-110 (AAV2-NGF): Targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons
Bishop, K. M., Hofer, E. K., Mehta, A., Ramirez, A., Sun, L., Tuszynski, M. H., & Bartus, R. T. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.03.004 · Cited by 88
Glial cell line-derived neurotrophic factor: distribution and pharmacology in the rat following a bolus intraventricular injection
Lapchak, P. A., Jiao, S., Collins, F., & Miller, P. J. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01265-6 · Cited by 87
GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis
Grundström, E., Lindholm, D., Johansson, A., Blennow, K., & Askmark, H. (2000) · Neuroreport · doi:10.1097/00001756-200006050-00037 · Cited by 86
Nerve Growth Factor (NGF) Loop 4 Dimeric Mimetics Activate ERK and AKT and Promote NGF-like Neurotrophic Effects
Xie, Y., Tisi, M. A., Yeo, T. T. S., & Longo, F. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005071200 · Cited by 85
Precursor of Brain-derived Neurotrophic Factor (proBDNF) Forms a Complex with Huntingtin-associated Protein-1 (HAP1) and Sortilin That Modulates proBDNF Trafficking, Degradation, and Processing
Yang, M., Lim, Y. P., Li, X., Zhong, J., & Zhou, X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.195347 · Cited by 85
Intranasal administration of nerve growth factor ameliorate β-amyloid deposition after traumatic brain injury in rats
Tian, L., Guo, R., Yue, X., Lv, Q., Ye, X., Wang, Z., Chen, Z., Wu, B., Xu, G., & Liu, X. (2012) · Brain Research · doi:10.1016/j.brainres.2011.12.059 · Cited by 84
Normal β-NGF content in Alzheimer's disease cerebral cortex and hippocampus
Allen, S. J., MacGowan, S. H., Treanor, J., Feeney, R. H., Wilcock, G. K., & Dawbarn, D. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90354-v · Cited by 82
Self-citation
Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration
Capsoni, S., Tiveron, C., Vignone, D., Amato, G., & Cattaneo, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007181107 · Cited by 81
MPP+ induced apoptotic cell death in SH-SY5Y neuroblastoma cells: An electron microscope study
Sheehan, J. P., Palmer, P. E., Helm, G. A., & Tuttle, J. B. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970501)48:3 · Cited by 81
Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of α‐synuclein in the substantia nigra
Halbach, O. V. B. U., Minichiello, L., & Unsicker, K. (2005) · The FASEB Journal · doi:10.1096/fj.05-3845fje · Cited by 79
GDNF delivery for Parkinson’s disease
Patel, N. K., & Gill, S. S. (2007) · Springer eBooks · doi:10.1007/978-3-211-33081-4_16 · Cited by 77
Self-citation
Intranasal “painless” Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice
Capsoni, S., Marinelli, S., Ceci, M., Vignone, D., Amato, G., Malerba, F., Paoletti, F., Meli, G., Viegi, A., Pavone, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037555 · Cited by 76
Compacted DNA Nanoparticle Gene Transfer of GDNF to the Rat Striatum Enhances the Survival of Grafted Fetal Dopamine Neurons
Yurek, D. M., Fletcher‐Turner, A., Kowalczyk, T. H., Padegimas, L., & Cooper, M. J. (2009) · Cell Transplantation · doi:10.3727/096368909x12483162196881 · Cited by 74

Research works printed but not linked: 1

Falconer, 1956, Wobbler (Wr), Mouse News Lett, 15, 23

Sorted by citations

BDNF as a Promising Therapeutic Agent in Parkinson’s Disease
Palasz, E., Wysocka, A., Gasiorowska, A., Chalimoniuk, M., Niewiadomski, W., & Niewiadomska, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031170 · Cited by 504
Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson’s disease
Whone, A., Luz, M., Boca, M., Woolley, M., Mooney, L., Dharia, S., Broadfoot, J., Cronin, D., Schroers, C., Barua, N. U., et al. (2019) · Brain · doi:10.1093/brain/awz023 · Cited by 282
Self-citation
The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review
Reich, N., & Hölscher, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.970925 · Cited by 248
Dendrimer-Based Drug Delivery Systems for Brain Targeting
Zhu, Y., Liu, C., & Pang, Z. (2019) · Biomolecules · doi:10.3390/biom9120790 · Cited by 220
Sodium Butyrate Prevents Memory Impairment by Re-Establishing BDNF and GDNF Expression in Experimental Pneumococcal Meningitis
Barichello, T., Generoso, J. S., Simões, L. R., Faller, C. J., Ceretta, R. A., Petronilho, F., Lopes-Borges, J., Valvassori, S. S., & Quevedo, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8914-3 · Cited by 125

See all 820

Authors: Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U., & Patel, N. K.
Affiliations: Frenchay Hospital (GB)
Corresponding author: Allen, Shelley J.
ORCID: Allen, Shelley J.
Shoemark, Deborah K.
Barua, Neil U.
Patel, Nikunj K.
Venue: Pharmacology & Therapeutics
Publisher: Elsevier BV
Published: 2013-05
Volume: 138
Issue: 2
Pages: 155-175
ISSN: 0163-7258 (ISSN-L)
DOI: 10.1016/j.pharmthera.2013.01.004
OpenAlex: W2006376003
Cited by: 820
References: 256
Citations by year: 2026: 42 · 2025: 68 · 2024: 80 · 2023: 74 · 2022: 64 · 2021: 68 · 2020: 49 · 2019: 56 · 2018: 66 · 2017: 53 · 2016: 71 · 2015: 48 · 2014: 63 · 2013: 17
FWCI: 6.77
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Pharmacology & Therapeutics (publishedVersion)
PubMed (publishedVersion)
Explore Bristol Research (submittedVersion)
Bristol Research (University of Bristol) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords: glial cell line-derived neurotrophic factor, nerve growth factor, brain-derived neurotrophic factor, neurotrophic factors, neurodegenerative diseases, Parkinson's disease, Alzheimer's disease, Huntington's disease, blood-brain barrier, viral gene therapy, small molecule agonists, neurotrophin receptors
MeSH terms: Animals, Humans, Ligands, Models, Molecular, Nerve Growth Factors, Brain-Derived Neurotrophic Factor, Neurodegenerative Diseases, Glial Cell Line-Derived Neurotrophic Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

GDNF, NGF and BDNF as therapeutic options for neurodegeneration

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks